Author:
Lebentrau S.,May M.,Maurer O.,Schostak M.,Lehsnau M.,Ecke T.,Al-Dumaini S.,Hallmann S.,Ahmed A.M.,Braun V.,Haferkamp A.,Bauer R.M.,Stief C.G.,Baumunk D.,Hoschke B.,Braun H.-P.,Schäfer C.,Hipp M.,Maurer J.,Braun K.-P.,Wolff I.,Brookman-May S.,Gilfrich C.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Leitlinienprogramm Onkologie (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 2.0, 1. Aktualisierung 09.2011
2. Schröder FH, Hugosson J, Roobol MJ et al (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366(11):981–990
3. Andriole GL, Crawford ED, Grubb RL III et al (2012) Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 104(2):125–132
4. U.S. Preventive Services Task Force (2013) Screening for Prostate Cancer, Topic Page. U.S. Preventive Services Task Force, Rockville. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening. html
5. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献